Compare GSK plc (GSK) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Warner Music Group Corp — how do they compare? GSK plc trades at $52.73 (market cap $101.34B), while Warner Music Group Corp trades at $28.42 (market cap $14.77B). The key difference: GSK plc is far larger — about 6.9× Warner Music Group Corp's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | WMG | |
|---|---|---|
Market Cap | $101.34B | $14.77B |
Sector | Health | Media |
52-Week High | $61.18 | $34.72 |
52-Week Low | $36.20 | $23.65 |
Enterprise Value | $121.95B | $18.97B |
Dividend Yield | 3.49% | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Warner Music Group (WMG) trades at $28.45, up 3.19% today, with a bearish technical signal despite recent earnings beats. The company shows steady revenue growth to $6.71B in 2025, though net margins have compressed to 5.44%. Recent acquisitions like Sureel AI (June 10, 2026) aim to strengthen IP monetization in the AI era, while analyst consensus remains bullish with a $40.40 price target.
WMG offers upside potential from streaming growth and AI initiatives, but faces risks from margin pressure and competitive content spending. The stock's high P/E of 33.71 suggests elevated expectations, requiring execution on profit improvement to justify valuation. Near-term support lies at $28, with resistance at $29.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
